Article
Uptake of risk-reducing medical interventions among female BRCA1/2 pathogenic variant carriers: A population-based study in British Columbia.
Gynecologic oncology - 1 Jul 2026
Lloyd-Ellis Sabrina, Kaur Paramdeep, Kwon Janice S, Dawson Lesa, Hanley Gillian E
Abstract excerpt
OBJECTIVE: Being a female with a germline BRCA1 or BRCA2 pathogenic variant (PV) elevates risks of developing breast and ovarian cancer, and guidelines recommend preventive interventions and increased screening. This study assesses the use of risk-reducing interventions. METHODS: This population-based retrospective study included all females who tested positive for a BRCA1/2 PV in British Columbia between 1996...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
